首頁 > 市場調查報告書 > 通訊

虛擬實境

市場調查報告書

商品編碼

1803032

全球 PTSD VR 治療市場預測（至 2032 年）：按類型、組件、模式、應用、最終用戶和地區進行分析

PTSD VR Therapy Market Forecasts to 2032 - Global Analysis By Type, Component, Modality, Application, End User and By Geography

出版日期: 2025年09月07日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球 PTSD VR 治療市場規模預計在 2025 年達到 17.4 億美元，到 2032 年將達到 54.9 億美元，預測期內的複合年成長率為 17.8%。

PTSD VR 療法是一種技術主導的治療方法利用身臨其境型虛擬實境環境，幫助患者在可控的治療環境中面對和處理創傷經歷。透過模擬針對患者創傷情況量身定做的真實場景，該療法可以促進暴露療法、情緒調節和認知重建。這種方法可以提高患者的參與度，減少迴避行為，並支持漸進式脫敏。臨床醫生會監測患者的反應並調整刺激以最佳化治療效果，這使得 VR 療法成為創傷後壓力症候群管理中個人化、循證護理的有前景的工具。

根據《國際環境研究與公共健康雜誌》的報道，基於虛擬實境的分級暴露療法（VR-GET）在減輕創傷後壓力症候群症狀方面表現出顯著的有效性。

VR硬體的快速發展和臨床有效性的驗證

臨床研究表明，在VR環境中進行的暴露療法可以顯著改善創傷後壓力症候群（PTSD）症狀，從而驗證了其治療潛力。與生物感測器和AI主導的反饋迴路的整合，進一步實現了治療的檢驗。隨著醫療服務提供者尋求可擴展的非侵入式解決方案，VR療法作為傳統療法的可行替代方案正日益受到關注。這些技術創新正在增強治療的真實感和患者參與度，使基於VR的干涉措施更加有效，並推動市場成長。

針對不同族群的證據有限

大多數臨床試驗都集中在退伍軍人或特定的創傷族群中，因此在兒童、老年人和文化背景多元的人群中，對其療效的理解仍有空白。缺乏全面的數據限制了VR技術的廣泛應用，並引發了對其普遍適用性的擔憂。此外，語言障礙和創傷應變中的文化差異可能會影響標準化VR模組的有效性。如果沒有涵蓋全球人群的、經過同行評審的嚴謹研究，監管部門的核准和保險報銷仍然有限。

擴展到更廣泛的心理健康

除了創傷後壓力症候群 (PTSD)，VR 療法已展現出治療多種心理健康問題的潛力，包括焦慮症、恐懼症、憂鬱症和藥物濫用。 VR 平台的模組化特性使其能夠快速調整治療內容，以滿足各種心理需求。隨著全球心理健康意識的增強，對便利、技術支援的介入措施的需求也日益成長。醫療保健機構正在探索將 VR 用於團體治療、正念訓練和認知康復，將其定位為下一代行為療法的基石，並開闢新的收益來源。

與現有療法的競爭

VR療法的新穎性必然會與現有治療方法競爭，例如藥物治療、認知行為療法 (CBT) 和眼動減敏與再處理 (EMDR)。這些方法已經經過數十年的臨床檢驗，並被醫生廣泛熟悉，使其成為許多醫療服務提供者的預設選擇。此外，報銷框架和臨床指南通常更傾向於傳統療法，這限制了VR的市場滲透。臨床醫師對VR解決方案的長期療效和成本效益的懷疑可能會進一步阻礙其應用。

COVID-19的影響：

疫情加速了人們對遠距和數位化心理健康解決方案的興趣，包括利用虛擬實境技術治療創傷後壓力症候群 (PTSD)。由於封鎖和保持社交距離措施擾亂了面對面的諮詢服務，醫療服務提供者尋求身臨其境型技術來確保護理的連續性。 VR 平台使患者能夠在家中接受暴露療法，減少了就診障礙並提高了治療依從性。然而，供應鏈中斷影響了硬體供應，經濟不確定性限制了機構對新技術的投資。

認知行為療法預計將成為預測期內最大的市場

認知行為療法 (CBT) 領域預計將在預測期內佔據最大市場佔有率，這得益於其結構化、循證的方法以及與 VR 產品的高度契合。 CBT 模組可以有效地轉化為身臨其境型場景，使患者能夠在受控環境中面對並重塑創傷記憶。 CBT 因其對各種創傷類型的適應性以及與數位平台的兼容性而受到臨床醫生的青睞。

預計創傷後壓力症候群 (PTSD) 領域在預測期內將以最高複合年成長率成長

由於人們對創傷相關疾病的認知和診斷不斷提高，因此預計創傷後壓力症候群 (PTSD) 領域將在預測期內實現最高成長率。 PTSD 在一般大眾、初期應變人員和醫療保健專業人員中的盛行率正在上升，目標人口不斷擴大。 VR 療法尤其受到年輕人的青睞，因為它提供了一種非侵入性且不受歧視的傳統諮詢替代方案。針對創傷的 VR 模組的持續研究以及機構對舉措日益成長的支持，正在推動市場擴張。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於心理健康意識的不斷增強以及數位醫療基礎設施的不斷普及。中國、日本和韓國等國家正大力投資VR技術，並將其融入其公共衛生體系。政府為促進心理健康和創傷復原而推出的支持舉措，也為市場成長創造了有利條件。

複合年成長率最高的地區：

預計北美將在預測期內呈現最高的複合年成長率，這得益於其強大的醫療基礎設施、新興技術的早期應用以及VR治療新興企業的強勁發展。該地區受益於優惠的報銷政策、積極的研究資金以及創傷後壓力症候群（PTSD）的高發生率，尤其是在退伍軍人群體中。科技公司與學術機構之間的合作正在激發創新，同時監管機構也越來越認可VR作為合法的治療工具。

提供免費客製化：

此報告的訂閱者可以使用以下免費自訂選項之一：

公司簡介
- 對最多三家其他市場公司進行全面分析
- 主要企業的SWOT分析（最多3家公司）
區域細分
- 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
競爭基準化分析
- 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 其他歐洲國家
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 其他南美
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東和非洲地區

第11章重大進展

協議、夥伴關係、合作和合資企業
收購與合併
新產品發布
業務擴展
其他關鍵策略

第12章公司概況

XRHealth
AppliedVR
Limbix
Psious
MyndVR
KindVR
Corpus VR
Cognihab
RelieVRx
Virtually Better
Neuro Rehab VR
PsyTech VR
oVRcome
Floreo
BehaVR
Oxford VR
Enosis Therapeutics

簡介目錄圖表

Product Code: SMRC30558

According to Stratistics MRC, the Global PTSD VR Therapy Market is accounted for $1.74 billion in 2025 and is expected to reach $5.49 billion by 2032 growing at a CAGR of 17.8% during the forecast period. PTSD VR therapy is a technology-driven treatment that uses immersive virtual reality environments to help individuals confront and process traumatic experiences in a controlled, therapeutic setting. By simulating realistic scenarios tailored to the patient's trauma, it facilitates exposure therapy, emotional regulation, and cognitive restructuring. This method enhances engagement, reduces avoidance behaviors, and supports gradual desensitization. Clinicians monitor responses and adjust stimuli to optimize outcomes, making VR therapy a promising tool for personalized, evidence-based care in post-traumatic stress disorder management.

According to International Journal of Environmental Research and Public Health, Virtual Reality-Based Graded Exposure Therapy (VR-GET) demonstrated a significantly larger effect size for reducing PTSD symptoms.

Market Dynamics:

Driver:

Rapid evolution of VR hardware & proven clinical efficacy

Clinical studies have demonstrated measurable improvements in PTSD symptoms through exposure therapy conducted in VR environments, validating its therapeutic potential. Integration with biometric sensors and AI-driven feedback loops is further elevating treatment personalization. As healthcare providers seek scalable and non-invasive solutions, VR therapy is gaining traction as a viable alternative to traditional methods. These innovations are enhancing therapeutic realism and patient engagement, making VR-based interventions more effective boosting the market growth.

Restraint:

Limited evidence for diverse populations

Most trials have focused on military veterans or specific trauma cohorts, leaving gaps in understanding efficacy among children, elderly patients, and culturally diverse populations. This lack of inclusive data limits broader adoption and raises concerns about generalizability. Additionally, language barriers and cultural nuances in trauma response may affect the effectiveness of standardized VR modules. Without robust, peer-reviewed studies encompassing global populations, regulatory approvals and insurance reimbursements remain constrained.

Opportunity:

Expansion into broader mental health

Beyond PTSD, VR therapy is showing potential in addressing a wider spectrum of mental health conditions such as anxiety disorders, phobias, depression, and substance abuse. The modular nature of VR platforms allows for rapid adaptation of therapeutic content to suit different psychological needs. As mental health awareness grows globally, demand for accessible, tech-enabled interventions is surging. Institutions are exploring VR for group therapy, mindfulness training, and cognitive rehabilitation, opening new revenue streams positioning VR as a cornerstone of next-generation behavioral healthcare.

Threat:

Competition from established therapies

The novelty, of VR therapy must contend with entrenched treatment modalities like pharmacotherapy, cognitive behavioral therapy (CBT), and EMDR (Eye Movement Desensitization and Reprocessing). These approaches have decades of clinical validation and widespread practitioner familiarity, making them the default choice for many providers. Moreover, reimbursement frameworks and clinical guidelines often favor conventional therapies, limiting VR's market penetration. Skepticism among clinicians regarding long-term efficacy and cost-effectiveness of VR solutions may further slow adoption.

Covid-19 Impact:

The pandemic accelerated interest in remote and digital mental health solutions, including VR-based PTSD therapy. Lockdowns and social distancing measures disrupted in-person counseling, prompting providers to explore immersive technologies for continuity of care. VR platforms enabled patients to undergo exposure therapy from home, reducing barriers to access and enhancing treatment adherence. However, supply chain disruptions affected hardware availability, and economic uncertainty limited institutional investments in new technologies.

The cognitive behavioral therapy segment is expected to be the largest during the forecast period

The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period due to its structured, evidence-based approach that aligns well with VR delivery. CBT modules can be effectively translated into immersive scenarios, allowing patients to confront and reframe traumatic memories in a controlled environment. The adaptability of CBT to various trauma types and its compatibility with digital platforms make it a preferred choice among clinicians.

The post-traumatic stress disorder (PTSD) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the post-traumatic stress disorder (PTSD) segment is predicted to witness the highest growth rate driven by increasing awareness and diagnosis of trauma-related conditions. Rising incidences of PTSD among civilians, first responders, and healthcare workers are expanding the target population. VR therapy offers a non-invasive, stigma-free alternative to traditional counseling, making it particularly appealing for younger demographics. Continued research into trauma-specific VR modules and growing institutional support for mental health initiatives are fueling market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share propelled by rising mental health awareness and expanding access to digital healthcare infrastructure. Countries like China, Japan, and South Korea are investing heavily in VR technologies and integrating them into public health systems. Government-backed initiatives promoting mental wellness and trauma recovery are creating favorable conditions for market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to robust healthcare infrastructure, early adoption of emerging technologies, and strong presence of VR therapy startups. The region benefits from favorable reimbursement policies, active research funding, and a high prevalence of PTSD cases, particularly among veterans. Collaborations between tech companies and academic institutions are accelerating innovation, while regulatory bodies are increasingly recognizing VR as a legitimate therapeutic tool.

Key players in the market

Some of the key players in PTSD VR Therapy Market include XRHealth, AppliedVR, Limbix, Psious, MyndVR, KindVR, Corpus VR, Cognihab, RelieVRx, Virtually Better, Neuro Rehab VR, PsyTech VR, oVRcome, Floreo, BehaVR, Oxford VR, and Enosis Therapeutics.

Key Developments:

In July 2025, PsyTech VR published a v2.0.7 product update announcing enhanced AI tools and also showcased at ACBS World Conference. The June update described incremental product improvements to treatment protocols and clinician tooling; conference presence (July) promoted clinical adoption.

In June 2025, Floreo announced the launch of a Scientific Advisory Board to advance evidence-based VR therapy for neurodivergent learners. Additionally, Floreo was selected by Center for Social Dynamics to expand VR ABA services in U.S. schools

In April 2025, Mynd Immersive announced an expansion delivering VR therapeutics to >150 U.S. senior-living communities. The release highlights partnerships (e.g., Select Rehabilitation, HTC VIVE, AT&T) to scale immersive therapeutics across senior care and post-acute settings.

Types Covered:

Exposure Therapy
Cognitive Behavioral Therapy
Eye Movement Desensitization and Reprocessing
Biofeedback-augmented VR therapy
Combined / Hybrid Therapy Models
Other Types

Components Covered:

Hardware
Software
Services
Other Components

Modalities Covered:

Immersive VR
Semi-Immersive
Non-Immersive

Applications Covered:

Depression
Anxiety Disorders
Post-Traumatic Stress Disorder (PTSD)
Pain Management
Addiction Management
Other Applications

End Users Covered:

Therapy Clinics & Rehabilitation Centers
Military & Defense
Hospitals & Clinics
Research & Academic Institutions
Homecare Settings
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global PTSD VR Therapy Market, By Type

5.1 Introduction
5.2 Exposure Therapy
5.3 Cognitive Behavioral Therapy
5.4 Eye Movement Desensitization and Reprocessing
5.5 Biofeedback-augmented VR therapy
5.6 Combined / Hybrid Therapy Models
5.7 Other Types

6 Global PTSD VR Therapy Market, By Component

6.1 Introduction
6.2 Hardware
- 6.2.1 Head-Mounted Displays (HMDs)
- 6.2.2 Controllers & Tracking Systems
- 6.2.3 Physiological Sensors
- 6.2.4 Haptics & peripherals
6.3 Software
- 6.3.1 Simulation Content & Scenario Libraries
- 6.3.2 Clinical Management & Analytics Software
6.4 Services
- 6.4.1 Software Customization & Integration Services
- 6.4.2 Clinical Implementation & Therapist Training
- 6.4.3 Maintenance & Support
6.5 Other Components

7 Global PTSD VR Therapy Market, By Modality

7.1 Introduction
7.2 Immersive VR
7.3 Semi-Immersive
7.4 Non-Immersive

8 Global PTSD VR Therapy Market, By Application

8.1 Introduction
8.2 Depression
8.3 Anxiety Disorders
8.4 Post-Traumatic Stress Disorder (PTSD)
8.5 Pain Management
8.6 Addiction Management
8.7 Other Applications

9 Global PTSD VR Therapy Market, By End User

9.1 Introduction
9.2 Therapy Clinics & Rehabilitation Centers
9.3 Military & Defense
9.4 Hospitals & Clinics
9.5 Research & Academic Institutions
9.6 Homecare Settings
9.7 Other End Users

10 Global PTSD VR Therapy Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 XRHealth
12.2 AppliedVR
12.3 Limbix
12.4 Psious
12.5 MyndVR
12.6 KindVR
12.7 Corpus VR
12.8 Cognihab
12.9 RelieVRx
12.10 Virtually Better
12.11 Neuro Rehab VR
12.12 PsyTech VR
12.13 oVRcome
12.14 Floreo
12.15 BehaVR
12.16 Oxford VR
12.17 Enosis Therapeutics

簡介目錄圖表

List of Tables

Table 1 Global PTSD VR Therapy Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global PTSD VR Therapy Market Outlook, By Type (2024-2032) ($MN)
Table 3 Global PTSD VR Therapy Market Outlook, By Exposure Therapy (2024-2032) ($MN)
Table 4 Global PTSD VR Therapy Market Outlook, By Cognitive Behavioral Therapy (2024-2032) ($MN)
Table 5 Global PTSD VR Therapy Market Outlook, By Eye Movement Desensitization and Reprocessing (2024-2032) ($MN)
Table 6 Global PTSD VR Therapy Market Outlook, By Biofeedback-augmented VR therapy (2024-2032) ($MN)
Table 7 Global PTSD VR Therapy Market Outlook, By Combined / Hybrid Therapy Models (2024-2032) ($MN)
Table 8 Global PTSD VR Therapy Market Outlook, By Other Types (2024-2032) ($MN)
Table 9 Global PTSD VR Therapy Market Outlook, By Component (2024-2032) ($MN)
Table 10 Global PTSD VR Therapy Market Outlook, By Hardware (2024-2032) ($MN)
Table 11 Global PTSD VR Therapy Market Outlook, By Head-Mounted Displays (HMDs) (2024-2032) ($MN)
Table 12 Global PTSD VR Therapy Market Outlook, By Controllers & Tracking Systems (2024-2032) ($MN)
Table 13 Global PTSD VR Therapy Market Outlook, By Physiological Sensors (2024-2032) ($MN)
Table 14 Global PTSD VR Therapy Market Outlook, By Haptics & peripherals (2024-2032) ($MN)
Table 15 Global PTSD VR Therapy Market Outlook, By Software (2024-2032) ($MN)
Table 16 Global PTSD VR Therapy Market Outlook, By Simulation Content & Scenario Libraries (2024-2032) ($MN)
Table 17 Global PTSD VR Therapy Market Outlook, By Clinical Management & Analytics Software (2024-2032) ($MN)
Table 18 Global PTSD VR Therapy Market Outlook, By Services (2024-2032) ($MN)
Table 19 Global PTSD VR Therapy Market Outlook, By Software Customization & Integration Services (2024-2032) ($MN)
Table 20 Global PTSD VR Therapy Market Outlook, By Clinical Implementation & Therapist Training (2024-2032) ($MN)
Table 21 Global PTSD VR Therapy Market Outlook, By Maintenance & Support (2024-2032) ($MN)
Table 22 Global PTSD VR Therapy Market Outlook, By Other Components (2024-2032) ($MN)
Table 23 Global PTSD VR Therapy Market Outlook, By Modality (2024-2032) ($MN)
Table 24 Global PTSD VR Therapy Market Outlook, By Immersive VR (2024-2032) ($MN)
Table 25 Global PTSD VR Therapy Market Outlook, By Semi-Immersive (2024-2032) ($MN)
Table 26 Global PTSD VR Therapy Market Outlook, By Non-Immersive (2024-2032) ($MN)
Table 27 Global PTSD VR Therapy Market Outlook, By Application (2024-2032) ($MN)
Table 28 Global PTSD VR Therapy Market Outlook, By Depression (2024-2032) ($MN)
Table 29 Global PTSD VR Therapy Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
Table 30 Global PTSD VR Therapy Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
Table 31 Global PTSD VR Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
Table 32 Global PTSD VR Therapy Market Outlook, By Addiction Management (2024-2032) ($MN)
Table 33 Global PTSD VR Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
Table 34 Global PTSD VR Therapy Market Outlook, By End User (2024-2032) ($MN)
Table 35 Global PTSD VR Therapy Market Outlook, By Therapy Clinics & Rehabilitation Centers (2024-2032) ($MN)
Table 36 Global PTSD VR Therapy Market Outlook, By Military & Defense (2024-2032) ($MN)
Table 37 Global PTSD VR Therapy Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 38 Global PTSD VR Therapy Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
Table 39 Global PTSD VR Therapy Market Outlook, By Homecare Settings (2024-2032) ($MN)
Table 40 Global PTSD VR Therapy Market Outlook, By Other End Users (2024-2032) ($MN)